FDA recall D-0988-2022

Teva Pharmaceuticals USA Inc · Class III · drug

Product

Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01

Reason for recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Distribution

Product was distributed nationwide in the US Market

Key facts

Status
Terminated
Initiation date
2022-05-18
Report date
2022-06-15
Termination date
2023-12-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0988-2022